CGEN
Compugen Ltd.
$1.65
+$0.03(+1.85%)
43
Overall
--
Value
36
Tech
50
Quality
Market Cap
$150.56M
Volume
313.78K
52W Range
$1.13 - $2.66
Target Price
$6.25
Company Overview
| Mkt Cap | $150.56M | Price | $1.65 |
| Volume | 313.78K | Change | +1.85% |
| P/E Ratio | -10.6 | Open | $1.65 |
| Revenue | $27.9M | Prev Close | $1.62 |
| Net Income | $-14.2M | 52W Range | $1.13 - $2.66 |
| Div Yield | N/A | Target | $6.25 |
| Overall | 43 | Value | -- |
| Quality | 50 | Technical | 36 |
No chart data available
Latest News
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdesk•15 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEN | $1.65 | +1.9% | 313.78K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |